摘要
目的:介绍1例骨髓增生异常综合征(MDS)转化的急性红白血病患者,复发后出现了Ph染色体及BCR-ABL融合基因。方法:对1例20岁的男性MDS-RAEB2患者进行持续细胞形态学、遗传学及分子生物学监测。结果:患者转化为急性红白血病(M6型),染色体正常男性核型,RT-PCR阴性,诱导缓解后短时间内复发,再诱导缓解后定期巩固治疗,1年后第2次复发,再诱导化疗未缓解,染色体46,XY,t(9,22),BCR-ABL融合基因阳性。结论:极少数情况下,MDS患者在疾病进展中会出现Ph染色体。
Objective:The Ph chromosome is found in the majority of CML cases,in approximately 15%~33% adult acute lymphoblastic leukemia,and in 2% acute myeloblastic leukemia cases.In MDS,however,the Ph chromosome is rarely involved.We describe a patient with acute erythroleukemia evolved from myelodysplastic syndrome(MDS) and the presenting as positive Philadelphia chromosome(Ph) after relapse.Method:The patient was a 20-year-old man who was diagnosed as refractory anemia with excess of blasts.Result:MDS progressed to acute erythrocytic leukemia later and chromosome analysis showed normal karyotypes.The karyotypes at second relapse showed: 46,XY,t(9,22) / and BCR-ABL fusion gene were positively detected by RT-PCR.Conclusion:Philadelphia chromosome and BCR-ABL fusion gene might be involved in the progression of MDS in some very rare cases.
出处
《临床血液学杂志》
CAS
2010年第5期517-519,共3页
Journal of Clinical Hematology
基金
国家科技支撑计划(No:2008BAI61B02)
江苏省卫生厅135重点人才基金(No:RC2002033)
苏州市社会发展及医药项目(No:SS08024)
江苏省高校自然科学研究项目(No:09KJB320015)